Covance in Biopharm Services Expansion
Covance Drug Development, a Princeton, New Jersey-headquartered contract research organization of Laboratory Corporation of America Holdings, a healthcare diagnostics company, will expand its biopharmaceutical chemistry, manufacturing, and control (BioPharmCMC) capabilities based in Harrogate, England, into leased space at the National Agri-Food Innovation Campus in York, England, which is purpose-built for laboratory and scientific services.
Opening in late 2017, the laboratory extension in York will provide BioPharmCMC solutions for biologic medicines, including antibodies, vaccines, biosimilars, and cell-based and gene therapies. BioPharmCMC solutions are part of a biologic’s development and manufacturing pathway to determine its safety, quality, identity, strength and purity.
